Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 834

1.

ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion.

Simoneau E, Katz MH, Lee JE, Tzeng CD.

Ann Surg Oncol. 2019 Mar 11. doi: 10.1245/s10434-019-07290-2. [Epub ahead of print] No abstract available.

PMID:
30859352
2.

Author Correction: Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.

Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ.

Nat Cell Biol. 2019 Mar 4. doi: 10.1038/s41556-019-0290-9. [Epub ahead of print]

PMID:
30833696
3.

Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG.

J Gastrointest Surg. 2019 Feb 28. doi: 10.1007/s11605-019-04126-y. [Epub ahead of print]

PMID:
30820801
4.

Metastatic colorectal cancer: The reality of the present and the optimism of the future.

Melstrom LG, Tzeng CD.

J Surg Oncol. 2019 Apr;119(5):547-548. doi: 10.1002/jso.25427. Epub 2019 Feb 26. No abstract available.

PMID:
30806484
5.

Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.

Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD.

HPB (Oxford). 2019 Feb 21. pii: S1365-182X(19)30066-8. doi: 10.1016/j.hpb.2019.01.011. [Epub ahead of print]

PMID:
30799277
6.

Reply to: Adhesion proteins: Suitable therapeutic targets or biomarkers of therapy response for endometriosis?

Rahmawati E, Yang WV, Tzeng CR.

Acta Obstet Gynecol Scand. 2019 Feb 8. doi: 10.1111/aogs.13566. [Epub ahead of print] No abstract available.

PMID:
30737768
7.

Impact of epidural analgesia on the systemic biomarker response after hepatic resection.

Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP.

Oncotarget. 2019 Jan 15;10(5):584-594. doi: 10.18632/oncotarget.26549. eCollection 2019 Jan 15.

8.

Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.

Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan 30. pii: S1365-182X(19)30008-5. doi: 10.1016/j.hpb.2018.12.006. [Epub ahead of print]

PMID:
30711243
9.

Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator.

Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Eur J Surg Oncol. 2019 Jan 24. pii: S0748-7983(19)30036-8. doi: 10.1016/j.ejso.2019.01.013. [Epub ahead of print]

PMID:
30704808
10.

Mitochondrial translocation of estrogen receptor β affords resistance to oxidative insult-induced apoptosis and contributes to the pathogenesis of endometriosis.

Liao TL, Lee YC, Tzeng CR, Wang YP, Chang HY, Lin YF, Kao SH.

Free Radic Biol Med. 2019 Jan 24;134:359-373. doi: 10.1016/j.freeradbiomed.2019.01.022. [Epub ahead of print]

PMID:
30684560
11.

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis.

Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG.

Pancreas. 2019 Feb;48(2):216-222. doi: 10.1097/MPA.0000000000001231.

PMID:
30629022
12.

Is it tumor encasement or arterial dissection/thrombosis? EUS to the rescue!

Cazacu IM, Singh BS, Tzeng CD, Tamm EP, Bhutani MS.

VideoGIE. 2019 Jan 1;4(1):24-26. doi: 10.1016/j.vgie.2018.10.007. eCollection 2019 Jan. No abstract available.

13.

Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.

Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD.

HPB (Oxford). 2018 Dec 3. pii: S1365-182X(18)34506-4. doi: 10.1016/j.hpb.2018.10.009. [Epub ahead of print]

PMID:
30522947
14.

Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma.

Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD.

Ann Surg Oncol. 2019 Feb;26(2):652. doi: 10.1245/s10434-018-07093-x. Epub 2018 Dec 11.

PMID:
30539487
15.

Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

HPB (Oxford). 2018 Nov 27. pii: S1365-182X(18)34525-8. doi: 10.1016/j.hpb.2018.10.018. [Epub ahead of print]

PMID:
30501986
16.

Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy.

Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003112. [Epub ahead of print]

PMID:
30499795
17.

Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy.

Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

Ann Surg Oncol. 2019 Jan;26(1):296. doi: 10.1245/s10434-018-7034-0. Epub 2018 Nov 21.

PMID:
30465224
18.

Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV Agents.

Lee JC, Lin CK, Tseng CK, Chen YL, Tzeng CC, Tseng CH.

Molecules. 2018 Nov 2;23(11). pii: E2863. doi: 10.3390/molecules23112863.

19.

Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo.

Cheng KW, Tseng CH, Tzeng CC, Leu YL, Cheng TC, Wang JY, Chang JM, Lu YC, Cheng CM, Chen IJ, Cheng YA, Chen YL, Cheng TL.

Pharmacol Res. 2019 Jan;139:41-49. doi: 10.1016/j.phrs.2018.10.029. Epub 2018 Nov 1.

PMID:
30391354
20.

Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.

Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA.

Clin Cancer Res. 2018 Nov 1. doi: 10.1158/1078-0432.CCR-18-1955. [Epub ahead of print]

PMID:
30385653
21.

Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases.

Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS.

Ann Surg Oncol. 2019 Jan;26(1):275-281. doi: 10.1245/s10434-018-6945-0. Epub 2018 Oct 25.

PMID:
30362064
22.

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003043. [Epub ahead of print]

PMID:
30339628
23.

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.

Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR.

Ann Surg Oncol. 2019 Feb;26(2):619-627. doi: 10.1245/s10434-018-6807-9. Epub 2018 Oct 15.

PMID:
30324485
24.

Gonadotropin-releasing hormone agonist induces downregulation of tensin 1 in women with endometriosis.

Rahmawati E, Yang WV, Lei YP, Maurya PK, Chen HW, Tzeng CR.

Acta Obstet Gynecol Scand. 2019 Feb;98(2):222-231. doi: 10.1111/aogs.13481. Epub 2018 Nov 11.

PMID:
30312486
25.

Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents.

Tang KW, Lin ZC, Chen YL, Tzeng CC, Fang JY, Tseng CH.

Int J Mol Sci. 2018 Oct 7;19(10). pii: E3061. doi: 10.3390/ijms19103061.

26.

Iatrogenic Teratoma Rupture during TVOR Complicated with Peritonitis, Pleuritis, and Septic Shock.

Wang PY, Chang YE, Lee YC, Tzeng CR.

Case Rep Obstet Gynecol. 2018 Sep 10;2018:3126436. doi: 10.1155/2018/3126436. eCollection 2018.

27.

Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy.

Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Jan;21(1):43-50. doi: 10.1016/j.hpb.2018.01.002. Epub 2018 Sep 25.

PMID:
30266496
28.

The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma.

Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG.

Am J Surg. 2018 Sep 6. pii: S0002-9610(18)30811-0. doi: 10.1016/j.amjsurg.2018.08.024. [Epub ahead of print]

PMID:
30224070
29.

Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C.

Surgery. 2019 Feb;165(2):329-336. doi: 10.1016/j.surg.2018.07.031. Epub 2018 Sep 6.

PMID:
30197278
30.

Letter to the Editor Regarding "ALPPS Improves Resectability Compared with Conventional Two-Stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis": When Innovation is Not Enough.

Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN.

Ann Surg. 2018 Aug 30. doi: 10.1097/SLA.0000000000003025. [Epub ahead of print] No abstract available.

PMID:
30169392
31.

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.

Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ.

Cancer Med. 2018 Oct;7(10):4880-4892. doi: 10.1002/cam4.1734. Epub 2018 Aug 27.

32.

Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies.

Lin YH, Chen YH, Chang HY, Au HK, Tzeng CR, Huang YH.

Int J Mol Sci. 2018 Aug 13;19(8). pii: E2385. doi: 10.3390/ijms19082385. Review.

33.

Long-term survival after post-hepatectomy liver failure for colorectal liver metastases.

Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad C.

HPB (Oxford). 2019 Mar;21(3):361-369. doi: 10.1016/j.hpb.2018.07.019. Epub 2018 Aug 9.

PMID:
30100391
34.

Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines.

Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD.

J Surg Res. 2018 Oct;230:148-154. doi: 10.1016/j.jss.2018.04.067. Epub 2018 May 31.

PMID:
30100032
35.

Surgical Resection for Recurrence After Two-Stage Hepatectomy for Colorectal Liver Metastases Is Feasible, Is Safe, and Improves Survival.

Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN.

J Gastrointest Surg. 2019 Jan;23(1):84-92. doi: 10.1007/s11605-018-3890-y. Epub 2018 Aug 6.

PMID:
30084064
36.

Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.

Miller DR, Tzeng CC, Farmer T, Keller ET, Caplan S, Chen YS, Chen YL, Lin MF.

Cancer Lett. 2018 Nov 1;436:96-108. doi: 10.1016/j.canlet.2018.07.039. Epub 2018 Aug 3.

PMID:
30077739
37.

Printable Graphene Oxide Micropatterns for a Bio-Subretinal Chip.

Yang JW, Tseng ML, Fu YM, Kang CH, Cheng YT, Kuo PH, Tzeng CK, Chiou SH, Wu CY, Chen GY.

Adv Healthc Mater. 2018 Sep;7(18):e1800365. doi: 10.1002/adhm.201800365. Epub 2018 Jul 26.

PMID:
30051620
38.

Visual Experience-Dependent Expression of Fn14 Is Required for Retinogeniculate Refinement.

Cheadle L, Tzeng CP, Kalish BT, Harmin DA, Rivera S, Ling E, Nagy MA, Hrvatin S, Hu L, Stroud H, Burkly LC, Chen C, Greenberg ME.

Neuron. 2018 Aug 8;99(3):525-539.e10. doi: 10.1016/j.neuron.2018.06.036. Epub 2018 Jul 19.

PMID:
30033152
39.

Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.

Vicente D, Ikoma N, Chiang YJ, Fournier K, Tzeng CD, Song S, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2018 Sep;25(9):2720-2730. doi: 10.1245/s10434-018-6638-8. Epub 2018 Jul 9.

PMID:
29987602
40.

Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX.

Peterson SL, Husnain M, Pollack T, Pimentel A, Loaiza-Bonilla A, Westendorf-Overley C, Ratermann K, Anthony L, Desimone P, Goel G, Kudrimoti M, Dineen S, Tzeng CD, Hosein PJ.

Anticancer Res. 2018 Jul;38(7):4035-4039. doi: 10.21873/anticanres.12692.

PMID:
29970528
41.

Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.

Chen S, Wang H, Li Z, You J, Wu QW, Zhao C, Tzeng CM, Zhang ZM.

Br J Cancer. 2018 May 1:182-192. doi: 10.1038/s41416-018-0119-5.

PMID:
29937544
42.

A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg.

Kuruvilla J, Tzeng CH, Cho SG, Kim SJ, Tang JL, Su Y, Wu J, Vargo R, Cheverton P.

Bone Marrow Transplant. 2018 Jun 12. doi: 10.1038/s41409-018-0253-y. [Epub ahead of print]

43.

DNA Methylation Profiling Reveals the Change of Inflammation-Associated ZC3H12D in Leukoaraiosis.

Huang WQ, Yi KH, Li Z, Wang H, Li ML, Cai LL, Lin HN, Lin Q, Tzeng CM.

Front Aging Neurosci. 2018 May 23;10:143. doi: 10.3389/fnagi.2018.00143. eCollection 2018.

44.

Live euploid birth and complete hydatid mole, followed by partial hydatid mole after ICSI.

Chung MT, Tzeng CR, Chen CH, Chan C, Chang YE, Wu YH, Chen CH.

J Assist Reprod Genet. 2018 Aug;35(8):1533-1536. doi: 10.1007/s10815-018-1224-3. Epub 2018 Jun 2. No abstract available.

PMID:
29860577
45.

Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy.

Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG.

Surgery. 2018 Sep;164(3):424-431. doi: 10.1016/j.surg.2018.04.014. Epub 2018 May 25.

PMID:
29807648
46.

The effects of tenure and promotion on surgeon productivity.

Lam A, Heslin MJ, Tzeng CD, Chen H.

J Surg Res. 2018 Jul;227:67-71. doi: 10.1016/j.jss.2018.02.020. Epub 2018 Mar 12.

PMID:
29804864
47.

RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.

Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C.

Ann Surg Oncol. 2018 Aug;25(8):2457-2466. doi: 10.1245/s10434-018-6517-3. Epub 2018 May 21.

PMID:
29786130
48.

Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Patency rates and outcomes associated with thrombosis.

Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD.

J Surg Oncol. 2018 Jun;117(8):1648-1654. doi: 10.1002/jso.25067. Epub 2018 May 3.

PMID:
29723419
49.

Discovery of Pyrazolo[4,3-c]quinolines Derivatives as Potential Anti-Inflammatory Agents through Inhibiting of NO Production.

Tseng CH, Tung CW, Peng SI, Chen YL, Tzeng CC, Cheng CM.

Molecules. 2018 Apr 28;23(5). pii: E1036. doi: 10.3390/molecules23051036.

50.

Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.

Lima PDA, Nivet AL, Wang Q, Chen YA, Leader A, Cheung A, Tzeng CR, Tsang BK.

Biol Reprod. 2018 Oct 1;99(4):838-852. doi: 10.1093/biolre/ioy096.

PMID:
29688269

Supplemental Content

Support Center